-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Northwest Biotherapeutics Inc quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
- Northwest Biotherapeutics Inc Interest Expense for the quarter ending March 31, 2024 was $1.52M, a 47.8% increase year-over-year.
- Northwest Biotherapeutics Inc Interest Expense for the twelve months ending March 31, 2024 was $5.73M, a 10.4% increase year-over-year.
- Northwest Biotherapeutics Inc annual Interest Expense for 2023 was $5.24M, a 13.6% decline from 2022.
- Northwest Biotherapeutics Inc annual Interest Expense for 2022 was $6.07M, a 21.1% increase from 2021.
- Northwest Biotherapeutics Inc annual Interest Expense for 2021 was $5.01M, a 41.4% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)